Kane Biotech Inc. Announces Increase to Private Placement Offering

WINNIPEG, MANITOBA--(Marketwire - February 20, 2008) - Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, announces that due to strong demand it has increased the current private placement offering (the "Offering"), first reported on February 12, 2008, from a maximum of 4,000,000 units ("Units") to 6,200,000 Units, for total gross proceeds of up to $1,550,000. As previously announced, each Unit will be comprised of one common share of the Company (a "Share") and one half of one Share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder to purchase one Share at a price of $0.40 for a period of 18 months from the date the Warrant is issued.